NovoCure Competitors and Similar CompaniesClear all

Lyell's competitors and similar companies include Zymeworks and Legend Biotech.
Lyell
Lyell
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
Zymeworks
Zymeworks
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
Legend Biotech
Legend Biotech
Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications.
Founding Date
Founding Date
2018
Founding Date
2003
Founding Date
2014
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
South San Francisco, US HQ
Bothell, US
Seattle, US
Locations
Vancouver, CA HQ
Seattle, US
Locations
Somerset, US HQ
Ghent, BE
Nanjing, CN
Hong Kong, HK
Dublin, IE
Piscataway, US
Employees
Employees
188
Employees
45519% increase
Employees
2,90012% increase
Valuation ($)
Valuation ($)
243.3 m
Valuation ($)
973.3 m
Valuation ($)
8.4 b

Financial

Revenue (est.)
Revenue (est.)
$36k (FY, 2025)
Revenue (est.)
$106m (FY, 2025)
Revenue (est.)
$1b (FY, 2025)
Net income
Net income
($274.4m) (FY, 2025)
Net income
($81.1m) (FY, 2025)
Net income
($296.8m) (FY, 2025)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 125.9m
Total funding raised
$ 150.5m
For sources of this data, please see the company profile

View Company Profiles

Zymeworks
HQ
Vancouver, CA
Employees
455↑ 19% increase

Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.

View company
Legend Biotech
HQ
Somerset, US
Employees
2,900↑ 12% increase

Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications.

View company